Cardiology-Dr.AsifUllah

Cardiology-Dr.AsifUllah Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Cardiology-Dr.AsifUllah, Medical and health, Kohat.

ڈاکٹر آصف اللّٰہ Dr Asif-ullah MBBS FCPS MHPE Dip HPE
ماہر امراض دل شوگر بلڈ پریشر کولیسٹرول دھڑکن گھبراہٹ
کال پر نمبر
+92 334 5705287
واٹس ایپ میسیج پر نمبر حاصل کریں
03159831403

https://www.facebook.com/profile.php?id=61585761463230

Article SummaryJournal: Circulation: Arrhythmia and Electrophysiology (Nov 27, 2024)Study: NODE-301 Part 1Intervention: ...
28/02/2026

Article Summary
Journal: Circulation: Arrhythmia and Electrophysiology (Nov 27, 2024)
Study: NODE-301 Part 1
Intervention: Self-administered intranasal etripamil 70 mg
Population: 156 patients with confirmed atrioventricular nodal–dependent PSVT
Study Design
Randomized, double-blind, placebo-controlled
2:1 randomization (107 etripamil, 49 placebo)
Out-of-hospital, self-administration during symptomatic PSVT
Excluded Wolff-Parkinson-White syndrome and ventricular tachycardia
Primary endpoint (conversion to sinus rhythm within 5 hours) not met
Shorter time-point analyses showed effectiveness
Key Findings
1. Symptom Relief
75% reported rapid pulse and palpitations pre-treatment
≥20% reported dizziness, dyspnea, anxiety, chest pain
Etripamil significantly improved symptom relief vs placebo
Higher Treatment Satisfaction (effectiveness and global satisfaction, P

Insulin dose
15/02/2026

Insulin dose

13/02/2026

The claim that degrees in medicine and law are becoming obsolete because artificial intelligence is advancing rapidly is provocative, but it requires careful unpacking, especially in high-stakes professions such as clinical medicine and jurisprudence.

First, there is a categorical distinction between knowledge acquisition and professional authority. Systems such as OpenAI’s large language models can perform at or near expert-level on standardized exams. However, professional practice in medicine or law is not exam performance; it involves licensing, accountability, ethical reasoning, fiduciary duty, uncertainty management, and legally recognized responsibility. AI currently augments cognition but does not assume liability. That difference is foundational.

Second, medicine, particularly clinical cardiology, surgery, emergency care, and critical care, is embodied, relational, and procedural. Clinical reasoning integrates probabilistic inference, pattern recognition, non-verbal cues, contextual social determinants, and risk-benefit negotiation under uncertainty. AI can assist with diagnostics, risk stratification, and literature synthesis. It does not obtain informed consent, perform bedside ultrasound, manage a crashing airway, or assume medicolegal responsibility. Even if AI supports decision-making, the physician remains the accountable agent.

Third, regulatory and sociotechnical inertia matters. Licensing bodies, malpractice frameworks, and hospital governance structures evolve far more slowly than AI model improvements. The diffusion of responsibility in autonomous decision systems remains unresolved legally and ethically. Until liability, trust calibration, validation in diverse populations, and bias mitigation are fully addressed, independent AI replacement of licensed professionals is unlikely.

Fourth, historical analogies are instructive. Automation in radiology, pathology, and anesthesiology was predicted to eliminate specialists decades ago. Instead, the fields transformed: productivity increased, sub-specialization expanded, and new competencies emerged, such as AI oversight, interventional techniques, and systems-based practice.

Where the concern has merit is in skill composition. Routine cognitive tasks, such as document drafting, chart summarization, precedent search, coding, and literature review, are increasingly automatable. Graduates who rely solely on memorized knowledge without procedural skill, human judgment, or adaptive reasoning may indeed face reduced differentiation. Therefore, the comparative advantage shifts toward integrative thinking, procedural expertise, leadership, and ethical stewardship of AI tools.

In synthesis, AI will likely reshape medicine and law rather than render their degrees wasteful. The long training period may increasingly include AI literacy, data interpretation, and human–machine collaboration. The economic return may depend less on credential alone and more on how effectively professionals leverage AI. For students, the rational strategy is not avoidance of medicine or law, but intentional adaptation: cultivate clinical mastery, procedural competence, systems thinking, communication, and technological fluency. In high-stakes domains involving life, liberty, and fiduciary trust, society still requires accountable human professionals, even if they practice alongside powerful AI systems.

10/02/2026

🫀 BIG PICTURE FRAME 🌍

🧠 Central thesis
Cardiovascular aging (CVA) and cardiovascular diseases (CVDs) are not parallel processes → they are mechanistically intertwined and mutually reinforcing.

🧠 Mnemonic
“Aging writes the script, disease plays the role”

---

📈 EPIDEMIOLOGY & CLINICAL CONTEXT

👵 Age is the dominant risk factor for CVD
• CVD prevalence ≈ 40% at age 40–59
• >80% at age ≥80

🧠 Mnemonic
“Age loads the gun, triggers come later”

---

🏗️ STRUCTURAL HALLMARKS OF CVA

🫀 Heart
• Concentric hypertrophy
• Myocardial fibrosis
• Valvular calcification

🧠 Vessels
• Intimal thickening
• Arterial stiffening
• Luminal dilation

🧠 Mnemonic
“Thick walls, stiff pipes, calcified doors”

---

⚙️ FUNCTIONAL CONSEQUENCES

📉 Diastolic dysfunction
• Prolonged relaxation
• Reduced ventricular filling

🏃 Stress intolerance
• Preserved rest function
• Reduced cardiac reserve

⚡ Electrical aging
• PR interval prolongation
• Conduction slowing

🧠 Mnemonic
“Relaxation fails before contraction”

---

🧬 CELLULAR DRIVERS OF CVA

🧓 Cellular Senescence

🫀 Cardiomyocytes
• Hypertrophy
• Contractile dysfunction
• SASP secretion

🧠 Endothelium
• Barrier disruption
• ICAM-1 upregulation
• Leukocyte adhesion

🧱 Fibroblasts & valves
• Myofibroblast activation
• ECM overproduction
• Valvular thickening

🧠 Mnemonic
“Old cells shout inflammation”

---

🔁 Phenotypic Transitions

🔄 EndMT
• Endothelial → mesenchymal
• Promotes fibrosis and stiffness

🔄 VSMC switching
• Contractile → synthetic
• ECM secretion and intimal hyperplasia

🔄 Fibroblast activation
• Quiescent → collagen-producing

🧠 Mnemonic
“Identity loss equals structural chaos”

---

💥 Cell Death Pathways

☠️ Apoptosis
• ↑ CM, VEC, VSMC death

🔥 Pyroptosis
• Inflammasome-mediated CM injury

⚡ Ferroptosis
• ROS-driven lipid peroxidation

🔩 Cuproptosis
• Copper-induced endothelial death

🧠 Mnemonic
“Aging kills by many weapons”

---

🧪 MOLECULAR PILLARS OF CVA

🔋 Metabolic Dysfunction

• ↓ Fatty acid oxidation
• Shift toward glycolysis
• ↓ ATP yield
• Toxic lipid accumulation

🧠 Mnemonic
“Fuel mismatch starves the heart”

---

🧯 Mitochondrial Failure

• Structural abnormalities
• Impaired mitophagy
• Excess ROS
• ↓ NO bioavailability

🧠 Mnemonic
“Bad mitochondria poison vessels”

---

🧬 Genomic Instability

• Telomere attrition
• DNA repair failure
• Progerin accumulation

🧠 Consequences
• CM senescence
• Vascular stiffness
• Fibrosis

🧠 Mnemonic
“Broken DNA stiffens arteries”

---

🧾 Epigenomic Drift

📉 Decline of
• SIRT1, SIRT2
• Proper histone methylation
• DNA methylation fidelity

📈 Dysregulated
• ncRNAs
• m6A RNA modification

🧠 Effects
• Hypertrophy
• Fibrosis
• Inflammation

🧠 Mnemonic
“Epigenetic noise drives aging”

---

🧹 Proteostasis Collapse

• ↓ Proteasome activity
• ↓ Heat shock proteins
• ↓ Autophagy

🧠 Outcome
• Accumulation of damaged proteins
• Reduced stress tolerance

🧠 Mnemonic
“Garbage overload ages tissue”

---

🔥 Chronic Inflammation

• IL-1β ↑
• IL-6 ↑
• TNF-α ↑

🧠 Effects
• Fibrosis
• Diastolic dysfunction
• Thrombosis risk

🧠 Mnemonic
“Inflammaging fuels heart failure”

---

🔁 FEEDBACK LOOP MODEL

🫀 Cardiac aging ↑ afterload
🧠 Vascular aging ↑ preload
🔥 Immune infiltration amplifies both

🧠 Mnemonic
“Heart ages vessels, vessels age heart”

---

🎯 TRANSLATIONAL IMPLICATIONS

🩺 Diagnostics
• Aging biomarkers predict disease earlier

💊 Therapeutics
• Targeting CVA can
→ prevent CVD
→ delay onset
→ improve outcomes

🧠 Strategic shift
From disease-centric → aging-centric cardiology

🧠 Mnemonic
“Treat aging to treat disease”

---

🏁 FINAL SYNTHESIS 🧠

🫀 CVA is not benign aging
⚙️ It is an active, targetable, biological process
🎯 Intervening upstream in CVA offers the strongest leverage for CVD prevention

10/02/2026

high-yield enumeration of the key findings from this Lancet CTT Collaboration paper

---

🔬 STUDY CORE 🧠

📚 Individual participant data meta-analysis
👥 154,664 participants
🧪 23 large, double-blind RCTs
⏱ Median follow-up ≈ 4–5 years
🎯 Focus: adverse effects listed in statin product labels (SmPCs)

---

🧠 CENTRAL QUESTION ❓

Do statins causally produce the long list of “undesirable effects” claimed in product labels?

---

✅ CONFIRMED ADVERSE EFFECTS (CAUSAL, RCT-LEVEL EVIDENCE)

🦵 Muscle effects
• Rare severe myopathy / rhabdomyolysis
• Mild muscle symptoms → small excess, mainly in year 1
🧠 Mnemonic: “Muscle early, muscle mild”

🍬 New-onset diabetes
• Moderate, dose-dependent risk
• Mostly in patients already near diabetic threshold
🧠 Mnemonic: “Statins unmask diabetes, not create it”

---

⚠️ NEW FINDINGS FROM THIS STUDY (66 SmPC outcomes tested)

After strict false discovery rate control ⏳📉

Only 4 of 66 outcomes showed significant excess risk 👇

🧪 Liver biochemistry abnormalities
• ↑ Transaminases
• Other liver function test changes
• Dose-dependent effect
• Very small absolute excess

IVT Decision Making: “Disabling” ThresholdDisabling DeficitPrevents return to work or baseline activities (even with low...
05/02/2026

IVT Decision Making: “Disabling” Threshold

Disabling Deficit
Prevents return to work or baseline activities (even with low NIHSS). Treat immediately; no need to wait for advanced imaging. 🚨💉

Non-Disabling Deficit
Isolated sensory symptoms, minor facial drift, no functional loss. Do not treat with IVT (Class 3, no benefit). Preferred strategy: Dual Antiplatelet Therapy (DAPT). ❌🩸

Extended Windows & Wake-Up Strokes (4.5–9 h)

Indication
Stroke of unknown onset (wake-up stroke) or 4.5–9 h from last known well.

Core (infarct) vs Salvageable tissue
Determined by DWI-FLAIR mismatch or CT perfusion core/penumbra ratios.

Target Mismatch
IV thrombolysis is reasonable if a mismatch is detected on automated perfusion imaging (CTP/MRI). ⏳🧠

Prehospital & Systems of Care

911 Call → Mobile Stroke Unit (MSU) + Destination Triage
Class 1: Diagnose and treat IVT on scene for fastest onset-to-treatment. 🚑⚡

Local Stroke Center
Direct transport for suspected LVO (bypass local center) is Class 2b, reasonable if added delay is less than 30 minutes.

EVT-Capable Center
Class 3 (no benefit) if travel time exceeds 45–60 minutes compared with a well-functioning transfer system.

Thrombolysis: Agent Switch

Tenecteplase (TNK)
Class 1 (equal standing). Single bolus 0.25 mg/kg (maximum 25 mg). Workflow advantage with non-inferior efficacy. 💉✅

Alteplase (tPA)
Standard dosing: 0.9 mg/kg (10% bolus, 90% infusion over 60 minutes).

EVT Selection: “Large Core” Expansion (Class 1)

Patient
Anterior circulation proximal LVO (ICA or M1).

Time
Within 6 hours from onset.

Severity
NIHSS ≥6.

Pre-stroke mRS
0–1.

Imaging
ASPECTS 3–5 (large core).

Outcome
Endovascular thrombectomy recommended to reduce mortality and improve functional outcome. 🚀🧠

Posterior Circulation: Basilar Artery Occlusion (BAO) – The Basilar Mandate (Class 1)

Pathology
Basilar artery occlusion.

Time Window
Up to 24 hours.

Severity
NIHSS ≥10.

Imaging
PC-ASPECTS ≥6 (mild ischemia, viable brainstem).

Action
Mechanical thrombectomy recommended. 🔴🛠️

Antiplatelet Strategy: DAPT Decision Tree

High Risk (ABCD² ≥4) or Minor Stroke (NIHSS ≤3)
Class 1: Clopidogrel plus aspirin for 21 days.

Non-cardioembolic AIS or High-Risk TIA (

05/02/2026
05/02/2026
Contrast-Induced Nephropathy (CIN)Definition↑ Serum creatinine ≥ 0.5 mg/dL OR ≥ 25% from baseline within 48–72 hours aft...
05/02/2026

Contrast-Induced Nephropathy (CIN)

Definition

↑ Serum creatinine ≥ 0.5 mg/dL OR ≥ 25% from baseline within 48–72 hours after contrast exposure

Peak creatinine: 2–5 days

Returns to baseline: ≈ 14 days

Risk Factors

Chronic kidney disease (eGFR < 60 ml/min/1.73 m²)

Diabetes mellitus, hypertension, congestive heart failure, age > 75 years

Volume depletion, anemia

Nephrotoxic drugs (NSAIDs, aminoglycosides, etc.)

High contrast volume (> 100 ml)

Pathophysiology

Renal vasoconstriction → medullary hypoxia

Reactive oxygen species–mediated injury

Direct tubular epithelial toxicity

Clinical Course

Usually non-oliguric acute kidney injury

Serum creatinine begins to rise within 24 hours

Peaks at 3–5 days

Prevention

Hydration: 0.9% normal saline at 1 ml/kg/hour for 6–12 hours before and after contrast

Sodium bicarbonate: 3 ml/kg/hour for 1 hour pre-procedure, then 1 ml/kg/hour for 6 hours post-procedure (evidence controversial)

Use low- or iso-osmolar contrast media and the lowest possible volume

Hold metformin on the day of procedure and for 48 hours afterward

Consider high-intensity statin prior to contrast exposure

Management

Supportive care with optimization of volume status

Monitor serum creatinine and urine output

Renal replacement therapy rarely required (< 1%)

Mnemonic for Risk Factors: CHDFVA

C – Chronic kidney disease

H – Hypertension, heart failure

D – Diabetes mellitus

F – Female s*x, fluid depletion

V – High volume of contrast

A – Age > 75 years

Key Pearls

CIN is the third leading cause of hospital-acquired (iatrogenic) acute kidney injury

Most cases are reversible within two weeks

Prevention is far more effective than treatment

High-risk patients require close monitoring

Dialysis in toxicity....
05/02/2026

Dialysis in toxicity....

2025 Perspective on Resistant Hypertension in CKD 🩺🧠Resistant hypertension is exceedingly common in patients with chroni...
30/01/2026

2025 Perspective on Resistant Hypertension in CKD 🩺🧠
Resistant hypertension is exceedingly common in patients with chronic kidney disease (CKD) and is tightly linked to faster renal function decline and markedly increased cardiovascular morbidity and mortality ❤️‍🩹. Its management has therefore become a central priority in nephrology and cardiovascular medicine.
🎯 Blood Pressure Targets in CKD
Recent international guidelines now define clearer BP goals for CKD populations:
• Standard office BP target →

Address

Kohat
26000

Opening Hours

Monday 15:30 - 20:00
Tuesday 03:30 - 20:00
Wednesday 15:30 - 20:00
Friday 15:30 - 20:00
Saturday 08:00 - 17:00
Sunday 08:00 - 14:00

Telephone

+923459381162

Website

Alerts

Be the first to know and let us send you an email when Cardiology-Dr.AsifUllah posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram